Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • mnandita
    Junior Member
    • Dec 2011
    • 7

    #1

    Starting concentration of sample/control in ChIP Seq

    Given the little amounts of DNA obtained after ChIP, are analysis algorithms equipped to normalize data across input/mock/test ips if different amounts of starting material were used in each case to make the libraries?

    So if i have 10 ng of IP test, but 40 ng of input and 100 ng of mock, should I necessarily make all libraries from 10 ng only, or can I take all the DNA I have for each of the experiments?
  • ETHANol
    Senior Member
    • Feb 2010
    • 308

    #2
    You should absolutely use the smallest amount of DNA from your samples in all your libraries. In your example that would be 10 ng. The main reason is because PCR induces biases with each cycle (exponentially I believe), so if you are amplifying one sample less then other, the PCR bias won't be transferred equally between them.

    More simply, samples should be treated equally, to do that you need to use the same amount of starting material.

    One other thing, mock IP isn't really a good control. Just use input and your ChIP.
    --------------
    Ethan

    Comment

    • mnandita
      Junior Member
      • Dec 2011
      • 7

      #3
      Thanks Ethan. I agree with that (reg. starting with same amounts).

      As for the mock control- if your Ab is not very good, and there is sufficient amount of non-specific DNA pull down that does not show up in the input, how do you control for it without a mock? I do not think the mock is dispensable, except in cases where you have a very specific Ab.
      Last edited by mnandita; 12-15-2011, 10:04 AM.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:13 AM
      0 responses
      17 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 10:48 AM
      0 responses
      18 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...